Current Approaches to Treating Low-Risk MDS

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

XV Eurasian Hematology-Oncology Congress - EHOC 2024

Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
Events

Playback speed

10 seconds

Current Approaches to Treating Low-Risk MDS

By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Guillermo Garcia-Manero

41 views

September 16, 2024

Comments 0

MDS and MPN

Current and Future Treatment Landscape of Myelofibrosis

XV Eurasian Hematology-Oncology Congress - EHOC 2024

R. Komrokji

141 views

Eosinophilia: How To Manage the Orphan MPN

XV Eurasian Hematology-Oncology Congress - EHOC 2024

H. Hamed

6 views

Secondary Solid Development Ph- MPNs: Frequency, Characteristics and…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Aksoy

Biochemical Properties of Red Blood Cells in PV

XV Eurasian Hematology-Oncology Congress - EHOC 2024

W. Lebowa

Myelofibrosis Case Discussion: Patient With Splanchnic Venous Thromb…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

W. Lebowa

13 views

MDS: What's Current in Classification and Risk Stratification

XV Eurasian Hematology-Oncology Congress - EHOC 2024

R. Komrokji

23 views

A Case of Thalassemia Minor Coexisting with Chronic Myeloproliferati…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Buyukasik

9 views

Retrospective Analysis of Primary MF Patients in Azerbaijan

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Guluyev

11 views

Clinical Impact of CALR Mutation in Patients With Essential Thromboc…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Aksoy

10 views